Related references
Note: Only part of the references are listed.Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
Fishing anti(lymph)angiogenic drugs with zebrafish
Melissa Garcia-Caballero et al.
DRUG DISCOVERY TODAY (2018)
Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1
Jie Lu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation
Dominik Kraus et al.
CELLULAR ONCOLOGY (2018)
Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective
Rindert Missiaen et al.
VASCULAR PHARMACOLOGY (2017)
Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake
Muheeb Beg et al.
ELIFE (2017)
The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects
Javier A. Garcia-Vilas et al.
CANCER LETTERS (2017)
Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway
Qunyi Li et al.
FITOTERAPIA (2016)
Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone
Daniel H. Paulus et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells
Samik Basu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
Jermaine Goveia et al.
EMBO MOLECULAR MEDICINE (2014)
The Marine Fungal Metabolite, AD0157, Inhibits Angiogenesis by Targeting the Akt Signaling Pathway
Melissa Garcia-Caballero et al.
MARINE DRUGS (2014)
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes the Akt pathway
Melissa Garcia-Caballero et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling
Claudia Fumarola et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Katrien De Bock et al.
CELL (2013)
Role of Endothelial Cell Metabolism in Vessel Sprouting
Katrien De Bock et al.
CELL METABOLISM (2013)
Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary
Auxiliadora Lopez-Jimenez et al.
EUROPEAN JOURNAL OF NUTRITION (2013)
Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis
Guo-Xiang Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force
F. Polet et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Control of vessel sprouting by genetic and metabolic determinants
Guy Eelen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling
Jiahua Jiang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects
S. M. El Sayed et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
Pierre Sonveaux et al.
PLOS ONE (2012)
Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis
Frederique Vegran et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Silybin and Dehydrosilybin Decrease Glucose Uptake by Inhibiting GLUT Proteins
Tianzuo Zhan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
Melissa Garcia-Caballero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Antiangiogenic Activity of 2-Deoxy-D-Glucose
Jaime R. Merchan et al.
PLOS ONE (2010)
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Playing only one instrument may be not enough: limitations and future of the antianglogenic treatment of cancer
Ana R. Quesada et al.
BIOESSAYS (2007)
Evaluation of the anti-angiogenic effect of aloe-emodin
C. Cardenas et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process
B Martínez-Poveda et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
2-NBDG as a fluorescent indicator for direct glucose uptake measurement
CH Zou et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2005)
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB:: implications for angioprevention and antiangiogenic therapy
RP Singh et al.
ONCOGENE (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Angiogenesis and signal transduction in endothelial cells
R Muñoz-Chápuli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Lonidamine causes inhibition of anglogenesis-related endothelial cell functions
D Del Bufalo et al.
NEOPLASIA (2004)
Flavonoids inhibit VEGF/VGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases
MH Kim
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
L Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Role of plasminogen activator-plasmin system in tumor angiogenesis
JM Rakic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge
S Rodríguez-Nieto et al.
FASEB JOURNAL (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
JM Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
